Hypoxia-inducible factor prolyl hydroxylase domain inhibitor may maintain hemoglobin synthesis at lower serum ferritin and transferrin saturation levels than darbepoetin alfa

• Chie Ogawa ,

  Roles Writing – original draft

  * E-mail: tato.ogawa@gmail.com

  Affiliations Maeda Institute of Renal Research, Kawasaki, Kanagawa, Japan, Biomarker Society, Inc., Kawasaki, Kanagawa, Japan

  https://orcid.org/0000-0002-9503-9711

  ⨯
• Ken Tsuchiya ,

  Contributed equally to this work with: Ken Tsuchiya

  Roles Supervision

  Affiliations Biomarker Society, Inc., Kawasaki, Kanagawa, Japan, Department of Blood Purification, Tokyo Women’s Medical University, Tokyo, Japan

  ⨯
• Naohisa Tomosugi,

  Roles Investigation

  Affiliations Biomarker Society, Inc., Kawasaki, Kanagawa, Japan, Division of Systems Bioscience for Drug Discovery Project Research Center, Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan

  ⨯
• Kunimi Maeda

  Roles Funding acquisition

  Affiliations Maeda Institute of Renal Research, Kawasaki, Kanagawa, Japan, Biomarker Society, Inc., Kawasaki, Kanagawa, Japan

  ⨯